Scott Roberts

Technology Executive | Board Member | Advisor & Investor

📍 San Francisco, California, United States🔄 Updated July 2026💼 36 investments📅 26 years investing🗓 Last invested Jun 2026
VC🌍 United States20+ investmentsInvested this quarter
36
Total investments
18
Early stage
2
Mid stage
3
Late stage
26y
Years active

Portfolio

32 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2026
Lumos Health builds AI that predicts how drugs affect multiple organ systems simultaneously — cardiac, renal, hepatic, respiratory, metabolic — from continuous physiological data. Every Phase I clinical trial monitors safety with disconnected, single-timepoint measurements analyzed weeks later. Lumos processes the same data your trial already collects — continuous ECG waveforms, vital signs, lab results, drug administration records — and predicts multi-organ drug effects in real time. Cross-organ interactions that single-endpoint monitoring misses become visible hours to days earlier. Our foundation model was trained on 42,000+ ICU patients and 200+ drugs. It learned how human physiology responds to pharmacological intervention by ingesting continuous waveforms fused with clinical data. In validation, the model discovered known drug-organ interactions — nephrotoxicity, respiratory depression, cardiac perturbation — in a fully unsupervised setting. No labels. No prior pharmacological knowledge. Just physiological signal. Built for the drugs that need it most: novel mechanisms with no historical safety database. RNA therapeutics. Gene therapies. Combination regimens. If there is no reference compound to benchmark against, Lumos provides the computational safety baseline. Founded by a Princeton mathematician, backed by pharma and healthcare investors, and advised by clinicians from Penn Medicine, Princeton, and Harvard. We are accepting early access partners for Phase I safety monitoring. Contact: zach@projectlumos.org
Investor
Apr 2026
Sirius is an autonomous revenue retention platform for high-growth consumer subscription brands. By integrating deeply with your core billing and analytics stack (i.e. Stripe, Amplitude, Mixpanel, Chargebee, and Salesforce), Sirius intelligently intercepts cancellation requests and deploys dynamic, personalized win-back strategies. We instantly recover revenue and boost LTV, retaining more than 20% of churning subscribers without human intervention.
Investor
Oct 2024
Improving team productivity and performance with AI. We focus on championing the individual, saving time tracking progress, improving skills, and helping teams focus on what matters, directly in their work tools.
Investor
Mar 2023
webAI helps enterprises build, deploy, and operate custom AI on infrastructure they own, not in someone else’s cloud. Built for mission-critical environments, webAI brings AI to your data so organizations can run private, specialized models with full data sovereignty, real-time performance, and predictable economics. From public sector and defense to aviation and manufacturing, organizations that require the most private AI platform choose webAI to move from experimentation to production faster, owning their intelligence instead of renting it.
Investor
Apr 2022
Bloks automatically captures your conversations and gives you more context to help you make the most of every interaction. Visit bloks.app to get started.
Investor
Jan 2022
Koji is the world’s most powerful Link in Bio platform. With hundreds of free apps created by Koji and its community of independent developers, the Koji Link in Bio gives leading Creators on TikTok, Instagram, Twitch, and other social media platforms new ways to engage audiences, connect with supporters, and monetize. Koji launched in March 2021 and has raised $36 million in venture capital.
Investor
Jan 2022
Rapidly build custom AI applications and automations — no coding required. Easily mix and match the latest models from OpenAI, Anthropic, Google, Mistral, Meta, and more.
Investor
Jan 2022
We help people achieve superhuman output by creating and leveraging their own custom-trained AI model to scale content output, organic impressions, lead generation and income in a fraction of the time. - Create and train an AI version of you that can work 24/7 and do multiple jobs at 100x the content output of a human - Automate your AI model to help bring in leads, lower customer acquisition cost, engage with community and retain clients - Connect with other creators in the YouAi community who are refining and expanding their AIs to scale revenue and increase income.
Investor
Jan 2022
Leland is a platform that helps people reach career and educational goals by connecting them with the coaching, courses, content, and community. Whether you are building your career, trying to get into school, upskilling, taking a test, or trying to reach any other goal, we can help you reach your goals. Join our community today to access events, free resources, and more.
Investor
Dec 2021
We pair cutting-edge technology with vetted writers to deliver quality content, fast. From blogs to ad copy and everything in between, we’ve got you covered.
Angel Investor
Dec 2021
The AI research company advancing visual intelligence through creator partnerships.
Investor
Nov 2021
A simple CRM for commercial real estate professionals.
Investor
Sep 2021
The fastest-growing enterprise software companies are product-led and seller-accelerated. Pairing the efficiency of product-led growth with the efficacy of enterprise sales requires real-time customer visibility. Pace equips sellers with relevant insights at the right time so they can spend time growing revenue, not combing through dashboards. Convert, retain, and grow customers by prioritizing time and effort on the users who need it most. Proactively uncover opportunities to accelerate revenue without spreadsheets, dashboards, or favors from engineering.
Investor
Jun 2021
Airspeed is a suite of Slack and mobile apps that provide fun and simple ways to connect with your teammates. Our family of apps improve employee engagement, retention, and productivity by creating a strong company culture. Airspeed makes it easy to welcome new hires, track employee milestones, send kudos, and learn who (and where) your coworkers are. Learn more about Airspeed’s app family below, or get connected with free resources at airspeed.com/blog.
Angel Investor
Jun 2021
The AI-First CRM for small and medium businesses.
Show all 32 investments ↓
Experience · 39 entries
All (39)
Investments (36)
Founder (2)
Board (1)
2026
Investor
Jun 2026
Lumos Health builds AI that predicts how drugs affect multiple organ systems simultaneously — cardiac, renal, hepatic, respiratory, metabolic — from continuous physiological data. Every Phase I clinical trial monitors safety with disconnected, single-timepoint measurements analyzed weeks later. Lumos processes the same data your trial already collects — continuous ECG waveforms, vital signs, lab results, drug administration records — and predicts multi-organ drug effects in real time. Cross-organ interactions that single-endpoint monitoring misses become visible hours to days earlier. Our foundation model was trained on 42,000+ ICU patients and 200+ drugs. It learned how human physiology responds to pharmacological intervention by ingesting continuous waveforms fused with clinical data. In validation, the model discovered known drug-organ interactions — nephrotoxicity, respiratory depression, cardiac perturbation — in a fully unsupervised setting. No labels. No prior pharmacological knowledge. Just physiological signal. Built for the drugs that need it most: novel mechanisms with no historical safety database. RNA therapeutics. Gene therapies. Combination regimens. If there is no reference compound to benchmark against, Lumos provides the computational safety baseline. Founded by a Princeton mathematician, backed by pharma and healthcare investors, and advised by clinicians from Penn Medicine, Princeton, and Harvard. We are accepting early access partners for Phase I safety monitoring. Contact: zach@projectlumos.org
Investor
Apr 2026
Sirius is an autonomous revenue retention platform for high-growth consumer subscription brands. By integrating deeply with your core billing and analytics stack (i.e. Stripe, Amplitude, Mixpanel, Chargebee, and Salesforce), Sirius intelligently intercepts cancellation requests and deploys dynamic, personalized win-back strategies. We instantly recover revenue and boost LTV, retaining more than 20% of churning subscribers without human intervention.
Board Member
Feb 2026
Voices is the world’s leading enterprise-class marketplace and platform to source voice over actors, ethically license voice AI and access custom voice data to train AI models. For more than two decades, the world’s biggest brands, like Shopify, Microsoft and Cisco, have used Voices to ‘find their voice’. The Voices talent base is composed of many millions of actors across the globe, who trust Voices to support their interests and help them find meaningful work.
2025
Investor
Mar 2025
Divergent has created the worlds first end-to-end software-hardware production system for industrial digital manufacturing – the Divergent Adaptive Production System (DAPS™) – allowing customers to design, additively manufacture, and automatically assemble complex structures for automotive, aerospace, and defense applications. DAPS transforms the economics and environmental impact of manufacturing complex structures for vehicles of all types by optimizing designs, dematerializing structures, and eliminating upfront capex.
2024
Investor
Oct 2024
Improving team productivity and performance with AI. We focus on championing the individual, saving time tracking progress, improving skills, and helping teams focus on what matters, directly in their work tools.
Show all 39 entries ↓
Investment activity
2000–2026 · 36 investments
200012012220131201412016120173201822019520202202172022520231202412025120263
Recent (last 2 years)Earlier